11β-hydroxylase deficiency risk factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
The most potent risk factor in the development of 11β-hydroxylase deficiency is the presence of family history of 11β-hydroxylase deficiency.
Risk Factors
The most potent risk factor in the development of 11β-hydroxylase deficiency is presence of family history of 11β-hydroxylase deficiency.[1]
References
- ↑ Hannah-Shmouni F, Chen W, Merke DP (2017). “Genetics of Congenital Adrenal Hyperplasia”. Endocrinol. Metab. Clin. North Am. 46 (2): 435–458. doi:10.1016/j.ecl.2017.01.008. PMID 28476231.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH